109 related articles for article (PubMed ID: 10960921)
1. Direct in vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance study.
Guerquin-Kern JL; Volk A; Chenu E; Lougerstay-Madec R; Monneret C; Florent JC; Carrez D; Croisy A
NMR Biomed; 2000 Aug; 13(5):306-10. PubMed ID: 10960921
[TBL] [Abstract][Full Text] [Related]
2. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
3. Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
Int J Cancer; 2001 Feb; 91(4):550-4. PubMed ID: 11251980
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.
Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
Cancer Chemother Pharmacol; 1996; 37(3):259-65. PubMed ID: 8529287
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.
Aboagye EO; Artemov D; Senter PD; Bhujwalla ZM
Cancer Res; 1998 Sep; 58(18):4075-8. PubMed ID: 9751613
[TBL] [Abstract][Full Text] [Related]
6. Tumor-selective prodrug activation by fusion protein-mediated catalysis.
Bosslet K; Czech J; Hoffmann D
Cancer Res; 1994 Apr; 54(8):2151-9. PubMed ID: 8174122
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
[TBL] [Abstract][Full Text] [Related]
8. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
Biela BH; Khawli LA; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
[TBL] [Abstract][Full Text] [Related]
9. Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model.
Tsukamoto Y; Kato Y; Ura M; Horii I; Ishikawa T; Ishitsuka H; Sugiyama Y
Biopharm Drug Dispos; 2001 Jan; 22(1):1-14. PubMed ID: 11745902
[TBL] [Abstract][Full Text] [Related]
10. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843.
Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK
Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962
[TBL] [Abstract][Full Text] [Related]
11. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
12. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
13. A new paclitaxel prodrug for use in ADEPT strategy.
Bouvier E; Thirot S; Schmidt F; Monneret C
Org Biomol Chem; 2003 Oct; 1(19):3343-52. PubMed ID: 14584798
[TBL] [Abstract][Full Text] [Related]
14. Covalently mucoadhesive amphiphilic prodrug of 5-fluorouracil for enhanced permeation and improved oral absorption.
Liu Y; Zhao D; Sun M; Wei W; Wang Y; Zhou J; Zhang R; Wang J; Zhang H; He Z; Kan Q; Sun J
Drug Deliv Transl Res; 2018 Jun; 8(3):645-656. PubMed ID: 29532356
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
Beall HD; Sloan KB
Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
[TBL] [Abstract][Full Text] [Related]
16. A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry
Adam C; Bray TL; Pérez-López AM; Tan EH; Rubio-Ruiz B; Baillache DJ; Houston DR; Salji MJ; Leung HY; Unciti-Broceta A
J Med Chem; 2022 Jan; 65(1):552-561. PubMed ID: 34979089
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
Beall HD; Sloan KB
Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
Stribbling SM; Martin J; Pedley RB; Boden JA; Sharma SK; Springer CJ
Cancer Chemother Pharmacol; 1997; 40(4):277-84. PubMed ID: 9225945
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs.
Schmidt Laugesen C; Steffansen B; Scherfig E; la Cour M
Acta Ophthalmol Scand; 2005 Apr; 83(2):184-90. PubMed ID: 15799730
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy.
Kamm YJ; Heerschap A; Rosenbusch G; Rietjens IM; Vervoort J; Wagener DJ
Magn Reson Med; 1996 Sep; 36(3):445-50. PubMed ID: 8875416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]